Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

How has the hereditary genetic testing market grown in recent years?

The market size for hereditary genetic testing has seen substantial growth in recent years. The market, which was valued at $21.47 billion in 2024, is projected to increase to $23.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the historic period include a higher incidence of genetic diseases, advancements in healthcare informatics, the development of telemedicine, increased awareness campaigns, and a surge in the number of genetic testing platforms.

How is the hereditary genetic testing market size expected to evolve during the forecast period?

The market size for hereditary genetic testing is predicted to experience significant expansion in the upcoming years, reaching a value of $36.23 billion in 2029 with a compound annual growth rate (CAGR) of 11.0%. The anticipated growth during this period can be linked to a surge in cancer incidences, an increase in genetic disorder prevalence, a growing demand for diagnostic tests, a rise in personalized medicine uptake, and an increase in clinical trials. Prominent trends for the forecast period comprise of advancements in technology, whole-genome sequencing, the integration of genetic information, bespoke medicine, and non-invasive prenatal testing.

Get your hereditary genetic testing market report here!

https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report

Which key drivers are propelling the hereditary genetic testing market’s growth?

The upward trend in cancer incidences is anticipated to fuel the expansion of the hereditary genetic testing market. Cancer is an assortment of diseases characterized by anomalous cell multiplication with the potential to infiltrate or metastasize to different body parts. The growing cancer incidences are due to elements like aging demographics, lifestyle modifications, environmental toxins, genetic susceptibilities, and enhanced diagnosis methods. Hereditary genetic testing aids in cancer prevention by detecting genetic variations linked with heightened risk, thus facilitating early monitoring and specific prevention tactics. For instance, the Australian Institute of Health and Welfare, a governmental agency based in Australia, reported in July 2024 that the number of diagnosed cancer cases in Australia rose from 156,781 in 2021 to 160,570 in 2022, indicating a yearly increase. Consequently, the rising incidence of cancer is accelerating the growth of the hereditary genetic testing market.

What are the market segments in the hereditary genetic testing industry?

The hereditary genetic testing market covered in this report is segmented –

1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types

2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing

3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies

Subsegments:

1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing

2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions

3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening

4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes and Congenital Diseases, Diagnostic Testing For Cancer and Tumor Profiling

5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities and Side Effects, Personalized Medicine and Treatment Optimization

6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp

Which leading companies are shaping the growth of the hereditary genetic testing market?

Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Inc., MyHeritage Ltd., Color Health Inc., MedGenome Inc., SOPHiA GENETICS SA, Devyser AB, Mapmygenome India Ltd., Igenomix S.L.

What key trends are currently impacting the hereditary genetic testing market’s development?

Top firms active in the hereditary genetic testing market are prioritizing the creation of innovative genomic solutions like multi-cancer multigene panels to improve early detection and tailor-made treatment alternatives. These panels are diagnostic tests capable of simultaneously examining numerous genes to identify genetic mutations linked to differing cancer varieties, thereby assisting in early detection and individualized treatment. For example, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, unveiled the Riskguard hereditary cancer test. This Riskguard test provides a customized review of gene-related and familial cancer risks by using a basic blood or saliva sample for detecting 10 prevalent cancers. It facilitates better comprehension of cancer risk, guides in structuring screening and treatment strategies, and evaluates family risks. Besides, it customizes treatment for patients already diagnosed with cancer and advances risk classification for individuals having a family history of cancer by locating actionable gene variants.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20559

Which geographic areas are influencing the growth of the hereditary genetic testing market?

North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Direct-To-Consumer (Dtc) Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Genetically Modified Fruits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report

Optogenetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: